121 related articles for article (PubMed ID: 8450496)
1. Chronic antagonist treatment does not alter the mode of interaction of dopamine with rat striatal dopamine receptors.
O'Boyle KM; Gavin KT; Harrison N
J Recept Res; 1993; 13(1-4):329-39. PubMed ID: 8450496
[TBL] [Abstract][Full Text] [Related]
2. Impaired ontogeny of striatal dopamine D1 and D2 binding sites after postnatal treatment of rats with SCH-23390 and spiroperidol.
Kostrzewa RM; Saleh MI
Brain Res Dev Brain Res; 1989 Jan; 45(1):95-101. PubMed ID: 2645067
[TBL] [Abstract][Full Text] [Related]
3. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
[TBL] [Abstract][Full Text] [Related]
4. D1 receptor binding in rat striatum: modification by various D1 and D2 antagonists, but not by sibutramine hydrochloride, antidepressants or treatments which enhance central dopaminergic function.
Cheetham SC; Kettle CJ; Martin KF; Heal DJ
J Neural Transm Gen Sect; 1995; 102(1):35-46. PubMed ID: 8785022
[TBL] [Abstract][Full Text] [Related]
5. Effect of SCH 39166, a novel dopamine D1 receptor antagonist, on [3H]acetylcholine release in rat striatal slices.
Tedford CE; Crosby G; Iorio LC; Chipkin RE
Eur J Pharmacol; 1992 Feb; 211(2):169-76. PubMed ID: 1535318
[TBL] [Abstract][Full Text] [Related]
6. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
LaHoste GJ; Marshall JF
Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
[TBL] [Abstract][Full Text] [Related]
7. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
Urwyler S; Markstein R
J Neurochem; 1986 Apr; 46(4):1058-67. PubMed ID: 2936868
[TBL] [Abstract][Full Text] [Related]
8. Effect of desipramine during infancy and preweanling on dorsal striatal dopamine D1 and D2 receptor binding in adolescence in the rat.
Hilakivi I; Rinne J; Marjamäki P
Pol J Pharmacol; 1999; 51(4):311-6. PubMed ID: 10540962
[TBL] [Abstract][Full Text] [Related]
9. Agonist and antagonist interactions with D1 dopamine receptors: agonist-induced masking of D1 receptors depends on intrinsic activity.
O'Boyle KM; Waddington JL
Neuropharmacology; 1992 Feb; 31(2):177-83. PubMed ID: 1532443
[TBL] [Abstract][Full Text] [Related]
10. Solubilization and reconstitution of dopamine D1 receptor from bovine striatal membranes: effects of agonist and antagonist pretreatment.
Srivastava LK; Ross GM; Bajwa SB; Mishra RK
Neurochem Res; 1990 Jun; 15(6):647-57. PubMed ID: 1977093
[TBL] [Abstract][Full Text] [Related]
11. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
Thomas KL; Rose S; Jenner P; Marsden CD
Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
[TBL] [Abstract][Full Text] [Related]
12. Preferential inhibition of ligand binding to calf striatal dopamine D1 receptors by SCH 23390.
Cross AJ; Mashal RD; Johnson JA; Owen F
Neuropharmacology; 1983 Nov; 22(11):1327-9. PubMed ID: 6141534
[TBL] [Abstract][Full Text] [Related]
13. Effect of chronic nicotine treatment and withdrawal on rat striatal D1 and D2 dopamine receptors.
Kirch DG; Taylor TR; Creese I; Xu SX; Wyatt RJ
J Pharm Pharmacol; 1992 Feb; 44(2):89-92. PubMed ID: 1352822
[TBL] [Abstract][Full Text] [Related]
14. Striatal D1- and D2-dopamine receptor sites are separately detectable in vivo.
Leslie CA; Bennett JP
Brain Res; 1987 Jul; 415(1):90-7. PubMed ID: 2957025
[TBL] [Abstract][Full Text] [Related]
15. Alpha-melanotropin hormone inhibits the binding of [3H]SCH 23390 to the dopamine D1 receptor in vitro.
Lezcano NE; Salvatierra NA; Celis ME
Eur J Pharmacol; 1998 Dec; 363(2-3):211-5. PubMed ID: 9881592
[TBL] [Abstract][Full Text] [Related]
16. Autoradiographic identification of D1 dopamine receptors labelled with [3H]dopamine: distribution, regulation and relationship to coupling.
Hervé D; Trovero F; Blanc G; Glowinski J; Tassin JP
Neuroscience; 1992; 46(3):687-700. PubMed ID: 1532052
[TBL] [Abstract][Full Text] [Related]
17. Effect of chronic haloperidol treatment on dopamine-induced inositol phosphate formation in rat brain slices.
Li R; Chuang DM; Wyatt RJ; Kirch DG
Neurochem Res; 1994 Jun; 19(6):673-8. PubMed ID: 8065524
[TBL] [Abstract][Full Text] [Related]
18. D2 receptor antagonists do not modify guanine nucleotide-sensitive interactions between dopamine and D1 dopamine receptors under in vitro conditions.
Farrell CB; Lawlor M; Dunne A; O'Boyle KM
J Neurochem; 1995 Sep; 65(3):1124-30. PubMed ID: 7643090
[TBL] [Abstract][Full Text] [Related]
19. Different plasticity changes in D1 and D2 receptors in rat striatal subregions following impairment of dopaminergic transmission.
Savasta M; Dubois A; Benavidès J; Scatton B
Neurosci Lett; 1988 Feb; 85(1):119-24. PubMed ID: 2834672
[TBL] [Abstract][Full Text] [Related]
20. Chronic haloperidol does not alter agonist affinity for dopamine receptors in vitro.
Meller E; Bohmaker K; Goldstein M; Schweitzer JW; Friedhoff AJ
Eur J Pharmacol; 1985 Mar; 109(3):389-94. PubMed ID: 3157587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
